An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study

Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement. 2021;17(12):1966–75.

Article  PubMed  Google Scholar 

GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.

Bynum JPW, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, Medicare expenditures, and hospital use. J Am Geriatr Soc. 2004;52(2):187–94.

Article  PubMed  Google Scholar 

Frytak JR, Henk HJ, Zhao Y, Bowman L, Flynn JA, Nelson M. Health service utilization among Alzheimer’s disease patients: evidence from managed care. Alzheimers Dement. 2008;4(5):361–7.

Article  PubMed  Google Scholar 

Lei L, Samus QM, Thomas KS, Maust DT. Medication costs and use of older Americans in assisted living settings: a nationally representative cross-sectional study. J Gen Intern Med. 2022;38(2):294–301.

PubMed  PubMed Central  Google Scholar 

Maust DT, Strominger J, Bynum JPW, Langa KM, Gerlach LB, Zivin K, Marcus SC. Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US. JAMA. 2020;324(7):706–8.

Article  PubMed  PubMed Central  Google Scholar 

2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052–81.

Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert ASB. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350: h2698.

Article  PubMed  PubMed Central  Google Scholar 

Wright RM, Roumani YF, Boudreau R, et al. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc. 2009;57(2):243–50.

Article  PubMed  PubMed Central  Google Scholar 

Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.

Article  PubMed  Google Scholar 

Grodstein F, Chang C-H, Capuano AW, Power MC, Marquez DX, Barnes LL, Bennett DA, James BD, Bynum JPW. Identification of dementia in recent Medicare claims data, compared with rigorous clinical assessments. J Gerontol A Biol Sci Med Sci. 2022;77(6):1272–8.

Article  PubMed  Google Scholar 

Bayliss EA, Shetterly SM, Drace ML, Norton JD, Maiyani M, Gleason KS, et al. Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: The OPTIMIZE pragmatic cluster randomized trial. JAMA Intern Med. 2022;182(5):534–43.

Article  PubMed  PubMed Central  Google Scholar 

Hoffman CM, Vordenberg SE, Leggett AN, Akinyemi E, Turnwald M, Maust DT. Insights into designing educational materials for persons living with dementia: a focus group study. BMC Geriatr. 2024;24(1):61.

Article  Google Scholar 

Aspinall SL, Springer SP, Zhao X, Cunningham FE, Thorpe CT, Semla TP, Shorr RI, Hanlon JT. Central nervous system medication burden and risk of recurrent serious falls and hip fractures in veterans affairs nursing home residents. J Am Geriatr Soc. 2019;67(1):74–80.

Article  PubMed  Google Scholar 

Hamilton A. Qualitative methods in rapid turn-around health services research. Health services research & development cyberseminar. 2013. https://www.hsrd.research.va.gov/for_researchers/cyber_seminars/archives/780-notes.pdf.

Taylor B, Henshall C, Kenyon S, Litchfield I, Greenfield S. Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open. 2018;8(10): e019993.

Article  PubMed  PubMed Central  Google Scholar 

Okeowo DA, Zaidi STR, Fylan B, Alldred DP. Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review. Int J Pharm Pract. 2023;31(2):126–52.

Article  PubMed  Google Scholar 

Silva Almodóvar A, Keller MS, Lee J, et al. Deprescribing medications among patients with multiple prescribers: a socioecological model. J Am Geriatr Soc. 2024;72(3):660–9.

Article  PubMed  Google Scholar 

Mansfield E, Noble N, Sanson-Fisher R, Mazza D, Bryant J. Primary care physicians’ perceived barriers to optimal dementia care: a systematic review. Gerontologist. 2019;59(6):e697–708.

Article  PubMed  Google Scholar 

Keller MS, Vordenberg SE, Steinman MA. Moving deprescribing upstream. J Gen Intern Med. 2022;37(13):3176–7.

Article  PubMed  PubMed Central  Google Scholar 

Weir K, Nickel B, Naganathan V, Bonner C, McCaffery K, Carter SM, McLachlan A, Jansen J. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. J Gerontol B Psychol Sci Soc Sci. 2018;73(7):e98–107.

Article  PubMed  Google Scholar 

Weir KR, Scherer AM, Vordenberg SE, Streit S, Jansen J, Jungo KT. The patient typology about deprescribing and medication-related decisions: a quantitative exploration. Basic Clin Pharmacol Toxicol. 2024;134(1):39–50.

Article  CAS  PubMed  Google Scholar 

Ailabouni NJ, Rebecca Weir K, Reeve E, Turner JT, Wilson Norton J, Gray SL. Barriers and enablers of older adults initiating a deprescribing conversation. Patient Educ Couns. 2022;105(3):615–24.

Article  PubMed  Google Scholar 

Boyd CM, Shetterly SM, Powers JD, et al. Evaluating the safety of an educational deprescribing intervention: lessons from the optimize trial. Drugs Aging. 2024;41(1):45–54.

Article  PubMed  Google Scholar 

Weir KR, Shang J, Choi J, Rana R, Vordenberg SE. Factors important to older adults who disagree with a deprescribing recommendation. JAMA Netw Open. 2023;6(8): e2337281.

Article  PubMed  PubMed Central  Google Scholar 

Vordenberg SE, Kirch M, Singer D, Solway E, Roberts JS, Zikmund-Fisher BJ, Kullgren JT. Interest in medication deprescribing among US adults aged 50–80. J Gen Intern Med. 2024. https://doi.org/10.1007/s11606-024-08945-x.

Article  PubMed  PubMed Central  Google Scholar 

Choi J, Vordenberg SE. Older adults' perceptions of deprescribing chronic benzodiazepines. J Am Pharm Assoc (2003). 2021;61(5):533–8.e3.

Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22(8):1094–100.

Article  PubMed  PubMed Central  Google Scholar 

Singh S, Li X, Cocoros NM, et al. High-risk medications in persons living with dementia: a randomized clinical trial. JAMA Intern Med. 2024;184(10):1426–33.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif